Source link : https://www.newshealth.biz/health-news/ema-recommends-approval-of-capvaxive-pneumococcal-vaccine/
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to prevent invasive disease and pneumonia caused by Streptococcus pneumoniae in people aged 18 years or older. There are approximately 100 different serotypes of pneumococcal bacteria, which can affect adults differently than children. Vaccine Overview […]
Author : News Health
Publish date : 2025-01-31 15:18:33
Copyright for syndicated content belongs to the linked Source.